Page last updated: 2024-08-21

evans blue and Liver Diseases

evans blue has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bacchella, T; Coelho, AM; D'Albuquerque, LA; Figueira, ER; Machado, MC; Pinheiro, RS; Rocha-Filho, JA; Rocha-Santos, V	1

Other Studies

1 other study(ies) available for evans blue and Liver Diseases

Article	Year
Pentoxifylline enhances the protective effects of hypertonic saline solution on liver ischemia reperfusion injury through inhibition of oxidative stress. Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:2 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Capillary Permeability; Disease Models, Animal; Drug Synergism; Evans Blue; Free Radical Scavengers; Interleukin-1; Interleukin-10; Ischemia; Lipid Peroxidation; Liver Diseases; Lung; Male; Oxidative Stress; Pentoxifylline; Permeability; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Saline Solution, Hypertonic; Tumor Necrosis Factor-alpha	2015

Article

Year

Pentoxifylline enhances the protective effects of hypertonic saline solution on liver ischemia reperfusion injury through inhibition of oxidative stress.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:2

Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Capillary Permeability; Disease Models, Animal; Drug Synergism; Evans Blue; Free Radical Scavengers; Interleukin-1; Interleukin-10; Ischemia; Lipid Peroxidation; Liver Diseases; Lung; Male; Oxidative Stress; Pentoxifylline; Permeability; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Saline Solution, Hypertonic; Tumor Necrosis Factor-alpha

2015